Free Trial

Wave Life Sciences (WVE) Stock Forecast & Price Target

$5.84
+0.11 (+1.92%)
(As of 07/19/2024 ET)

Wave Life Sciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 7 Wall Street analysts who have issued ratings for Wave Life Sciences in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 1 has given a hold rating, and 6 have given a buy rating for WVE.

Consensus Price Target

$13.17
125.46% Upside
High Forecast$19.00
Average Forecast$13.17
Low Forecast$5.00

According to the 7 analysts' twelve-month price targets for Wave Life Sciences, the average price target is $13.17. The highest price target for WVE is $19.00, while the lowest price target for WVE is $5.00. The average price target represents a forecasted upside of 125.46% from the current price of $5.84.

TypeCurrent Forecast
7/22/23 to 7/21/24
1 Month Ago
6/22/23 to 6/21/24
3 Months Ago
4/23/23 to 4/22/24
1 Year Ago
7/22/22 to 7/22/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.17$11.17$10.14$7.00
Forecasted Upside125.46% Upside99.05% Upside96.60% Upside72.98% Upside
Get Wave Life Sciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

WVE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WVE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Wave Life Sciences Stock vs. The Competition

TypeWave Life SciencesMedical CompaniesS&P 500
Consensus Rating Score
2.86
2.72
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside125.46% Upside3,241.50% Upside10.06% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/26/2024HC Wainwright
3 of 5 stars
 Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00+214.46%
6/25/2024Mizuho
2 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$19.00 ➝ $19.00+289.34%
5/15/2024Wells Fargo & Company
3 of 5 stars
 Initiated CoverageOverweight$11.00+88.36%
4/1/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$17.00+175.53%
3/7/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform ➝ Sector Perform$5.00-31.60%
12/19/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Schwartz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
12/19/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$5.00 ➝ $12.00+167.26%
7/5/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$7.00+96.63%
5/23/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$7.00 ➝ $5.00+31.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:11 PM ET.

WVE Forecast - Frequently Asked Questions

What is Wave Life Sciences' forecast for 2024?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Wave Life Sciences is $13.17, with a high forecast of $19.00 and a low forecast of $5.00.

Should I buy or sell Wave Life Sciences stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wave Life Sciences in the last year. There is currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" WVE shares.

Does Wave Life Sciences's stock price have much upside?

According to analysts, Wave Life Sciences's stock has a predicted upside of 136.10% based on their 12-month stock forecasts.

What analysts cover Wave Life Sciences?

Wave Life Sciences has been rated by research analysts at HC Wainwright, Mizuho, and Wells Fargo & Company in the past 90 days.

Do Wall Street analysts like Wave Life Sciences more than its competitors?

Analysts like Wave Life Sciences more than other "medical" companies. The consensus rating score for Wave Life Sciences is 2.86 while the average consensus rating score for "medical" companies is 2.72. Learn more on how WVE compares to other companies.


This page (NASDAQ:WVE) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners